Drug
Bgb 15025
Bgb 15025: highest development phase Phase 1, developed by BeiGene. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- BeiGene
Trials
| Drug | Phase | Indication |
|---|---|---|
| BGB-15025 NCT04649385 | Phase 1 | Advanced Solid Tumor |
Latest
No recent events.
Follow Bgb 15025 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.